CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN)

CUSIP: 23255M105

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / COMMON STOCK
Shares outstanding
4,330,313
Total 13F shares
18,528,720
Share change
+3,134,853
Total reported value
$49,097,876
Price per share
$2.65
Number of holders
67
Value change
+$8,211,551
Number of buys
32
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 23255M105?
CUSIP 23255M105 identifies CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CYCN - CYCLERION THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
58%
2,531,429
$6,885,000 31 Dec 2019
13F
EcoR1 Capital, LLC
13F
Company
42%
1,811,000
$4,926,000 31 Dec 2019
13F
BlackRock Finance, Inc.
13F
Company
37%
1,616,588
$4,398,000 31 Dec 2019
13F
MFN Partners Management, LP
13F
Company
34%
1,487,874
$4,047,000 31 Dec 2019
13F
Artal Group S.A.
13F
Company
31%
1,361,584
$3,703,000 31 Dec 2019
13F
VANGUARD GROUP INC
13F
Company
30%
1,291,625
$3,513,000 31 Dec 2019
13F
AWH Capital, L.P.
13F
Company
14%
590,000
$1,605,000 31 Dec 2019
13F
STATE STREET CORP
13F
Company
12%
526,667
$1,433,000 31 Dec 2019
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
8.1%
350,000
$952,000 31 Dec 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
6.9%
300,373
$817,000 31 Dec 2019
13F
NORTHERN TRUST CORP
13F
Company
6.6%
286,934
$780,000 31 Dec 2019
13F
D. E. Shaw & Co., Inc.
13F
Company
6.3%
272,783
$742,000 31 Dec 2019
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
5.4%
233,196
$634,000 31 Dec 2019
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
5.2%
226,031
$615,000 31 Dec 2019
13F
TRUSTCORE FINANCIAL SERVICES, LLC
13F
Company
4.6%
198,106
$539,000 31 Dec 2019
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
4%
173,250
$471,000 31 Dec 2019
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
3.4%
147,358
$401,000 31 Dec 2019
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
3.4%
145,809
$397,000 31 Dec 2019
13F
Point72 Asset Management, L.P.
13F
Company
3.2%
139,220
$379,000 31 Dec 2019
13F
Squarepoint Ops LLC
13F
Company
3.2%
136,918
$372,000 31 Dec 2019
13F
Madison Avenue Partners, LP
13F
Company
3.1%
132,569
$361,000 31 Dec 2019
13F
HORIZON KINETICS ASSET MANAGEMENT LLC
13F
Company
3%
129,311
$352,000 31 Dec 2019
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
2.4%
105,433
$287,000 31 Dec 2019
13F
COLONY GROUP LLC
13F
Company
2.4%
102,884
$280,000 31 Dec 2019
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
2.3%
100,857
$274,000 31 Dec 2019
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
2.3%
98,112
$267,000 31 Dec 2019
13F
Bank of New York Mellon Corp
13F
Company
2.2%
96,340
$262,000 31 Dec 2019
13F
Alambic Investment Management, L.P.
13F
Company
1%
44,266
$120,000 31 Dec 2019
13F
WELLS FARGO & COMPANY/MN
13F
Company
1%
43,474
$118,000 31 Dec 2019
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.99%
42,749
$116,277 31 Dec 2019
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.93%
40,244
$109,000 31 Dec 2019
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.85%
36,794
$100,000 31 Dec 2019
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.82%
35,470
$96,000 31 Dec 2019
13F
FIRST TRUST ADVISORS LP
13F
Company
0.8%
34,837
$95,000 31 Dec 2019
13F
MORGAN STANLEY
13F
Company
0.76%
33,048
$89,000 31 Dec 2019
13F
Brian C. Broderick
13F
Individual
0.74%
32,175
$88,000 31 Dec 2019
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.66%
28,398
$77,000 31 Dec 2019
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.65%
28,356
$77,000 31 Dec 2019
13F
UBS Group AG
13F
Company
0.65%
28,306
$77,000 31 Dec 2019
13F
Swiss National Bank
13F
Company
0.65%
28,230
$77,000 31 Dec 2019
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.65%
28,185
$77,000 31 Dec 2019
13F
RHUMBLINE ADVISERS
13F
Company
0.61%
26,338
$72,000 31 Dec 2019
13F
A.R.T. Advisors, LLC
13F
Company
0.56%
24,195
$66,000 31 Dec 2019
13F
Russell Investments Group, Ltd.
13F
Company
0.56%
24,209
$64,000 31 Dec 2019
13F
BARCLAYS PLC
13F
Company
0.55%
23,606
$64,000 31 Dec 2019
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.52%
22,604
$61,000 31 Dec 2019
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.42%
18,230
$50,000 31 Dec 2019
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.42%
18,050
$49,000 31 Dec 2019
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.39%
16,782
$46,000 31 Dec 2019
13F
AQR Arbitrage LLC
13F
Company
0.34%
14,842
$40,000 31 Dec 2019
13F

Institutional Holders of CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN) as of Q1 2020

As of 31 Mar 2020, CYCLERION THERAPEUTICS INC - COMMON STOCK (CYCN) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,528,720 shares. The largest 10 holders included FMR LLC, EcoR1 Capital, LLC, MFN Partners Management, LP, Artal Group S.A., BlackRock Inc., VANGUARD GROUP INC, Slate Path Capital LP, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, and Eversept Partners, LP. This page lists 67 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders
68
Q1 2020 holders
67
Holder diff
-1
Investor Q4 2019 Shares Q1 2020 Shares Share Diff Share Chg % Q4 2019 Value $ Q1 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .